Beyond Recognition: A Three-Dimensional Analytical Framework for Tumor-Immune Control Failure

Beyond Tumor Recognition: A Three-Dimensional Framework for Understanding Tumor–Immune Control Failure and Therapeutic InterventionThis research proposes a three-dimensional conceptual framework for understanding why effective tumor–immune control may fail, extending the analysis beyond tumor recognition alone.The framework integrates three interacting dimensions:Immune Compatibility: The degree of compatibility between tumor characteristics and the host immune system, including tumor-side antigen presentation and host-side immune competence.Immune Execution Efficiency: The ability of immune effectors to reach tumor cells, penetrate tumor tissue, engage their targets, and execute effective antitumor functions.Dynamic Adaptation: The reciprocal evolution of tumor populations and immune responses over time, including immune escape, clonal selection, and changes in tumor susceptibility.The tumor microenvironment is considered a cross-cutting modifier influencing all three dimensions through vascular, stromal, metabolic, and immunosuppressive mechanisms.The framework further introduces a proposed bottleneck-prioritization approach to identify potentially rate-limiting constraints on tumor–immune control and guide the development of mechanism-matched research strategies.This work is a hypothesis-generating conceptual framework, not a clinically validated model or treatment algorithm. Its proposed scientific contribution requires further experimental and prospective validation.Author: Mohammed Fuad Yousef AbuamraResearch Status: Conceptual Framework – Version 1.1Research Area: Cancer Biology, Tumor Immunology, Systems Oncology, and Translational Research.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-12
DOI
https://doi.org/10.5281/zenodo.24163288
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Beyond Recognition: A Three-Dimensional Analytical Framework for Tumor-Immune Control Failure

Mohammed Fuad Yousef Abuamra
Zenodo (CERN European Organization for Nuclear Research)
Cancer Immunotherapy and Biomarkers
preprint

Beyond Recognition: A Three-Dimensional Analytical Framework for Tumor-Immune Control Failure

Mohammed Fuad Yousef Abuamra
preprint en

Abstract

Beyond Tumor Recognition: A Three-Dimensional Framework for Understanding Tumor–Immune Control Failure and Therapeutic InterventionThis research proposes a three-dimensional conceptual framework for understanding why effective tumor–immune control may fail, extending the analysis beyond tumor recognition alone.The framework integrates three interacting dimensions:Immune Compatibility: The degree of compatibility between tumor characteristics and the host immune system, including tumor-side antigen presentation and host-side immune competence.Immune Execution Efficiency: The ability of immune effectors to reach tumor cells, penetrate tumor tissue, engage their targets, and execute effective antitumor functions.Dynamic Adaptation: The reciprocal evolution of tumor populations and immune responses over time, including immune escape, clonal selection, and changes in tumor susceptibility.The tumor microenvironment is considered a cross-cutting modifier influencing all three dimensions through vascular, stromal, metabolic, and immunosuppressive mechanisms.The framework further introduces a proposed bottleneck-prioritization approach to identify potentially rate-limiting constraints on tumor–immune control and guide the development of mechanism-matched research strategies.This work is a hypothesis-generating conceptual framework, not a clinically validated model or treatment algorithm. Its proposed scientific contribution requires further experimental and prospective validation.Author: Mohammed Fuad Yousef AbuamraResearch Status: Conceptual Framework – Version 1.1Research Area: Cancer Biology, Tumor Immunology, Systems Oncology, and Translational Research.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon